Revvity is a global leader in developing and delivering technologies and solutions across disease pathways, focused on advancing health science and human potential. They develop cutting-edge technologies in areas like biomarker identification, multi-omics, diagnostics, and informatics, supporting critical processes from disease research to diagnostics and treatment. Serving over 2 million scientists and operating in 190 countries, Revvity aims to accelerate scientific breakthroughs that address significant health challenges.
NHS Innovation Accelerator: Celebrating 10 years of success and what’s ahead
‘Innovations must not only be clinically effective but also shaped by real patient experiences to ensure they are truly impactful,’ – Mindy Simon, Co-Director, NHS Innovation Accelerator
